Cited by 139Ovarian function and disordersHypothalamic control of reproductive hormonesReproductive Health and Contraception

Three-step method for menstrual and oral contraceptive cycle verification

Open access
Schaumberg, Mia A., Jenkins, David G., Janse de Jonge, Xanne A.K., Emmerton, Lynne M., Skinner, Tina L.·2017·Journal of Science and Medicine in Sport

Abstract

Objectives Fluctuating endogenous and exogenous ovarian hormones may influence exercise parameters; yet control and verification of ovarian hormone status is rarely reported and limits current exercise science and sports medicine research. The purpose of this study was to determine the effectiveness of an individualised three-step method in identifying the mid-luteal or high hormone phase in endogenous and exogenous hormone cycles in recreationally-active women and determine hormone and demographic characteristics associated with unsuccessful classification.Design Cross-sectional study design.Methods Fifty-four recreationally-active women who were either long-term oral contraceptive users (n=28) or experiencing regular natural menstrual cycles (n=26) completed step-wise menstrual mapping, urinary ovulation prediction testing and venous blood sampling for serum/plasma hormone analysis on two days, 6-12days after positive ovulation prediction to verify ovarian hormone concentrations.Results Mid-luteal phase was successfully verified in 100% of oral contraceptive users, and 70% of naturally-menstruating women. Thirty percent of participants were classified as luteal phase deficient; when excluded, the success of the method was 89%. Lower age, body fat and longer menstrual cycles were significantly associated with luteal phase deficiency.Conclusions A step-wise method including menstrual cycle mapping, urinary ovulation prediction and serum/plasma hormone measurement was effective at verifying ovarian hormone status. Additional consideration of age, body fat and cycle length enhanced identification of luteal phase deficiency in physically-active women. These findings enable the development of stricter exclusion criteria for female participants in research studies and minimise the influence of ovarian hormone variations within sports and exercise science and medicine research.

Integrity signals

Registry

Crossref · 10.1016/j.jsams.2016.08.013

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. Burgomaster, KA, Howarth, KR, Phillips, SM, et al., Similar metabolic adaptations during exercise after low volume sprint interval and traditional endurance training in humans. The Journal of physiology, 2008. 586(1): p. 151-160.
  2. Hsu, AR, Barnholt, KE, Grundmann, NK, Lin, JH, McCallum, SW, and Friedlander, AL, Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia. Journal of applied physiology (Bethesda, Md : 1985), 2006. 100(6): p. 2031-2040.
  3. Ready, AE, Eynon, RB, and Cunningham, DA, Effect of interval training and detraining on anaerobic fitness in women. Canadian Journal of Applied Sport Sciences, 1981. 6(3): p. 114-118.
  4. Rossiter, HB, Kowalchuk, JM, and Whipp, BJ, A test to establish maximum o 2 uptake despite no plateau in the o 2 uptake response to ramp incremental exercise. Journal of applied physiology (Bethesda, Md : 1985), 2006. 100(3): p. 764-770.
  5. Schaumberg, MA, Jenkins, DG, Jonge, XAd, Emmerton, LM, and Skinner, TL, Three-step method for menstrual and oral contraceptive cycle verification. J Sci Med Sport. DOI: http://dx.doi.org/10.1016/j.jsams.2016.08.013 (21.7-23.4) (21.7-23.4) (21.7-23.4) (21.8-24.2) (21.8-24.2) (21.8-24.2) Fat mass (kg) 20.7±4.8 (18.7-22.7) 20.5±4.6 (18.6-22.4) 20.1±2.0 (18.2-22.0) 22.7±4.7 (20.0-25.4) 22.6±5.0 (19.8-25.5) 22.7±4.7 (20.0-25.4) Lean body mass (kg) 40.6±4.4 (38.8-42.5) 40.6±4.1 (38.9-42.3) 40.2±4.3 (38.3-42.1) 41.1±5.7 (37.8-44.4) 41.4±5.5 (38.2-44.6) 41.6±5.6 (38.3-44.8) Lean body mass -legs (kg) 13.6±1.8 (12.9-14.4) 13.8±1.9 (13.0-14.5) 13.5±1.8 (12.7-14.3) 13.8±2.5 (12.4-15.3) 14.0±2.5 (12.5-15.4) 14.1±2.6 (12.6-15.6) Body fat (%) 32.3±4.8 (30.3-34.3) 32.1±4.8 (30.1-34.0) 32.0±4.6 (30.0-34.0) 34.2±4.8 (31.5-37.0) 33.9±5.0 (31.0-36.8) 34.0±5.0 (31.1-36.9) Hormone and blood measures Oestradiol (pg.mL -1 ) 5.6 [5.0-10.3] (5.7-13.5) 5.1[5.0-10.2] (-11.0-63.8) 9.2[5.0-11.8] (6.7-16.2) 136.4±61.9 (102.1-170.7) 107.8±73.1 (67.3-148.3) 68.8[40.8-123.6] (47.4-121.7) Progestogen (ng.mL -1 ) 0.6±0.3 (0.4-0.7) · DOI

Cited by

Sorted by citations

Authors
Schaumberg, M. A., Jenkins, D. G., Janse de Jonge, X. A. K., Emmerton, L. M., & Skinner, T. L.
Affiliations
  • The University of Queensland (AU)
  • Curtin University (AU)
Corresponding author
Schaumberg, Mia A.
Venue
Journal of Science and Medicine in Sport
Publisher
Elsevier BV
Published
2017-11
Volume
20
Issue
11
Pages
965-969
ISSN
1440-2440 (ISSN-L)
OpenAlex
W2510295929
Cited by
139
References
31
Citations by year
2026: 17 · 2025: 25 · 2024: 17 · 2023: 19 · 2022: 12 · 2021: 22 · 2020: 16 · 2019: 5 · 2018: 5 · 2017: 1
FWCI
4.87
Type
journal article
Language
en
Open access
Locations
  • Journal of science and medicine in sport (publishedVersion)
  • PubMed (publishedVersion)
  • eSpace (Curtin University) (submittedVersion)
  • NOVA (University of Newcastle Australia) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Keywords
oral contraceptives, luteal phase, luteal phase deficiency, serum hormone measurement, fat mass, menstrual cycle length
MeSH terms
Adult, Age Factors, Contraceptives, Oral, Cross-Sectional Studies, Estradiol, Female, Humans, Luteal Phase, Menstruation Disturbances, Ovulation, Progesterone, Time Factors, Biomarkers, Exercise, Adiposity, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review